Curcumin as a potential target for COVID19: A Concept Letter
| dc.contributor.author | Perera, P.K. | |
| dc.contributor.author | Meedeniya, A.C.B. | |
| dc.date.accessioned | 2026-01-26T06:16:27Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Clinically, COVID-19 disease is variable, ranging from asymptomatic infection to multi-organ failure and death. At the onset of the pandemic in early 2020, approx. 80% of people infected with SARS CoV-2, did not develop symptoms; approx. 13% developed severe disease needing respiratory support and approx. 7% requiring intensive care, with clinical presentation including acute respiratory disease syndrome, sepsis, and multi-organ failure. Infection and illness were largely ... | |
| dc.identifier.citation | Perera, P.K., & Meedeniya, A.C.B. (2021). Curcumin as a potential target for COVID19: A Concept Letter. Academia Letters, Article 3484. https://doi.org/10.20935/AL3484 | |
| dc.identifier.issn | 2771-9359 | |
| dc.identifier.uri | https://doi.org/10.20935/AL3484 | |
| dc.identifier.uri | https://archive.cmb.ac.lk/handle/70130/8486 | |
| dc.language.iso | en | |
| dc.publisher | Academia Letters | |
| dc.subject | COVID-19 | |
| dc.subject | Curcumin | |
| dc.title | Curcumin as a potential target for COVID19: A Concept Letter | |
| dc.type | Article |